서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 301 to 360 of 539

Issue DateTitle / Author(s) / CitationFileAltmetrics
2012-12
Role of Adjuvant Chemoradiotherapy for Duodenal Cancer A Single Center Experience

Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W.

American Journal of Clinical Oncology, Vol.35 No.6, pp.533-536

DOI
2012-12
Body Mass Index Is Not Associated with Treatment Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Korean Data
view fileDOI
2012-12
Phase 2 Study of Everolimus Monotherapy in Patients With Nonfunctioning Neuroendocrine Tumors or Pheochromocytomas/Paragangliomas
DOI
2012-12
International models of investigator-initiated trials: implications for Japan
DOI
2012-12
The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines
DOI
2013-01
Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer
DOI
2013-03
Concordance of ATM (ataxia telangiectasia mutated) immunohistochemistry between biopsy or metastatic tumor samples and primary tumors in gastric cancer patients
DOI
2013-03
CD24 expression predicts distant metastasis in extrahepatic bile duct cancer
DOI
2013-04
Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy
DOI
2013-04
Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer
DOI
2013-04
Outcomes of surgery aiming at curative resection in good responder to induction chemotherapy for gastric cancer with distant metastases
DOI
2013-05
Targeted Sequencing of Cancer-Related Genes in Colorectal Cancer Using Next-Generation Sequencing
DOI
2013-05
Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy
DOI
2013-05
Role of chemotherapy for advanced/recurrent gastric cancer: An individual-patient-data meta-analysis
DOI
2013-05
Free-breathing dynamic contrast-enhanced MRI of the abdomen and chest using a radial gradient echo sequence with K-space weighted image contrast (KWIC)
DOI
2013-05
Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer
DOI
2013-06
Differing effects of adjuvant chemotherapy according to BRCA1 nuclear expression in gastric cancer
DOI
2013-06
RAD51C-Deficient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib
DOI
2013-07
Survival Outcomes and Prognostic Factors of Transcatheter Arterial Chemoembolization for Hepatic Neuroendocrine Metastases

Hur, Saebeom; Chung, Jin Wook; Kim, Hyo-Cheol; Oh, Do-Youn; Lee, Se-Hoon; Bang, Yung-Jue; Kim, Woo Ho

Journal of Vascular and Interventional Radiology, Vol.24 No.7, pp.947-956

DOI
2013-07
OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells
DOI
2013-09
Adjuvant and Neoadjuvant Therapy for Gastric Cancer

Oh, Do-Youn; Bang, Yung-Jue

Current Treatment Options in Oncology, Vol.14 No.3, pp.311-320

DOI
2013-09
Postoperative chemoradiotherapy following pancreaticoduodenectomy Impact of dose-volumetric parameters on the development of diabetes mellitus

Eom, K.; Chie, E. K.; Kim, K.; Jang, J. J.; Kim, S. W.; Oh, D. Y.; Im, S. A.; Kim, T. Y.; Bang, Y. J.; Ha, S. W.

Strahlentherapie und Onkologie, Vol.189 No.9, pp.753-758

DOI
2013-10
CRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth

Kim, Tai Young; Jackson, Sarah; Xiong, Yue; Whitsett, Timothy G.; Lobello, Janine R.; Weiss, Glen J.; Le Tran, Nhan; Bang, Yung-Jue; Der, Channing J.

Proceedings of the National Academy of Sciences of the United States of America, Vol.110 No.42, pp.16868-16873

DOI
2013-10
Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survival
DOI
2013-11
Nomogram Prediction of Survival and Recurrence in Patients With Extrahepatic Bile Duct Cancer Undergoing Curative Resection Followed by Adjuvant Chemoradiation Therapy

Song, Changhoon; Kim, Kyubo; Chie, Eui Kyu; Kim, Jin Ho; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W.

International Journal of Radiation Oncology Biology Physics, Vol.87 No.3, pp.499-504

DOI
2013-11
Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study
DOI
2013-11
Disease-Free Survival as a Surrogate for Overall Survival in Adjuvant Trials of Gastric Cancer: A Meta-Analysis
DOI
2013-11
Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis
DOI
2013-11
Clinicopathologic Analysis of ROS1-Rearranged Non-Small-Cell Lung Cancer and Proposal of a Diagnostic Algorithm
DOI
2013-12
Registry of gastric cancer treatment evaluation (REGATE): II treatment practice

Ter-Ovanesov, Mikhail; Yalcin, Suayib; Zalcberg, John; Hitier, Simon; Bang, Yung-Jue; Wu, Chew-Wun; Roth, Arnaud

Asia-Pacific Journal of Clinical Oncology, Vol.9 No.4, pp.373-380

DOI
2013-12
Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancer
DOI
2013-12
The influence of the treatment response on the impact of resection margin status after preoperative chemoradiotherapy in locally advanced rectal cancer
view fileDOI
2013-12
Establishment and characterization of seven human breast cancer cell lines including two triple-negative cell lines
DOI
2013-12
Clinical Implications of VEGF, TGF-beta 1, and IL-1 beta in Patients with Advanced Non-small Cell Lung Cancer
DOI
2014-01
Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker
DOI
2014-02
FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study
DOI
2014-03
Registry of gastric cancer treatment evaluation (REGATE): I baseline disease characteristics

Bang, Yung-Jue; Yalcin, Suayib; Roth, Arnaud; Hitier, Simon; Ter-Ovanesov, Mikhail; Wu, Chew-Wun; Zalcberg, John

Asia-Pacific Journal of Clinical Oncology, Vol.10 No.1, pp.38-52

DOI
2014-06
Testican-1-mediated epithelial-mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer

Kim, H-P; Han, S-W; Song, S-H; Jeong, E-G; Lee, M-Y; Hwang, D.; Im, S-A; Bang, Y-J; Kim, T-Y

Oncogene, Vol.33 No.25, pp.3334-3341

DOI
2014-07
A Phase I Study of Oral Paclitaxel with a Novel P-Glycoprotein Inhibitor, HIVI30181A, in Patients with Advanced Solid Cancer
DOI
2014-07
The Impact of Body Mass Index Dynamics on Survival of Patients With Advanced Pancreatic Cancer Receiving Chemotherapy

Choi, Younak; Kim, Tae-Yong; Lee, Kyung-hun; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue

Journal of Pain and Symptom Management, Vol.48 No.1, pp.13-25

DOI
2014-07
Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of HER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTANA- A Randomized, Phase III Study
DOI
2014-07
Quality of Life in the Trastuzumab for Gastric Cancer Trial
DOI
2014-07
A New Isolated Mediastinal Lymph Node or Small Pulmonary Nodule Arising during Breast Cancer Surveillance Following Curative Surgery: Clinical Factors That Differentiate Malignant from Benign Lesions
DOI
2014-08
A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer

Kang, Y-K; Rha, S. Y.; Tassone, P.; Barriuso, J.; Yu, R.; Szado, T.; Garg, A.; Bang, Y-J

British Journal of Cancer, Vol.111 No.4, pp.660-666

DOI
2014-08
Impact of Multimodality Approach for Patients with Leptomeningeal Metastases from Solid Tumors
view fileDOI
2014-08
Immunohistochemical Features Associated with Sensitivity to Lapatinib-plus-Capecitabine and Resistance to Trastuzumab in HER2-positive Breast Cancer
2014-09
Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer
DOI
2014-09
Prediction of survival in terminally ill cancer patients at the time of terminal cancer diagnosis
DOI
2014-09
Sunitinib in metastatic renal cell carcinoma: An ethnic Asian subpopulation analysis for safety and efficacy
DOI
2014-11
Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
DOI
2014-11
Crizotinib in ROS1-Rearranged Non-Small-Cell Lung Cancer
DOI
2014-11
A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma
view fileDOI
2014-11
Chemoradiotherapy for Extrahepatic Bile Duct Cancer with Gross Residual Disease after Surgery
2014-11
Effect of neoadjuvant chemotherapy on postoperative morbidity and mortality in patients with locally advanced gastric cancer

Ahn, H. S.; Jeong, S-H; Son, Y. G.; Lee, H-J; Im, S-A; Bang, Y-J; Kim, H-H; Yang, H-K

British Journal of Surgery, Vol.101 No.12, pp.1560-1565

DOI
2015-01
TGF-β suppresses COX-2 expression by tristetraprolin-mediated RNA destabilization in A549 human lung cancer cells
DOI
2015-01
KRAS mutation is associated with worse prognosis in stage III or high-risk stage II colon cancer patients treated with adjuvant FOLFOX
DOI
2015-03
Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells
view fileDOI
2015-03
Treatment for unresectable gastric cancer

Kim, Tae-Yong; Oh, Do-Youn; Bang, Yung-Jue

대한의사협회지, Vol.58 No.3, pp.209-215

DOI
2015-04
Prognostic value of splenic artery invasion in patients undergoing adjuvant chemoradiotherapy after distal pancreatectomy for pancreatic adenocarcinoma
DOI
2015-06
A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer
DOI
15 6 7 8 9